NO972620L - RANTES peptid og fragmenter og blandinger omfattende det for behandling av inflammasjon - Google Patents

RANTES peptid og fragmenter og blandinger omfattende det for behandling av inflammasjon

Info

Publication number
NO972620L
NO972620L NO972620A NO972620A NO972620L NO 972620 L NO972620 L NO 972620L NO 972620 A NO972620 A NO 972620A NO 972620 A NO972620 A NO 972620A NO 972620 L NO972620 L NO 972620L
Authority
NO
Norway
Prior art keywords
inflammation
fragments
mixtures
treatment
rantes peptide
Prior art date
Application number
NO972620A
Other languages
English (en)
Other versions
NO972620D0 (no
Inventor
Amanda Elizabeth Inn Proudfoot
Timothy Nigel Carl Wells
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9424835.8A external-priority patent/GB9424835D0/en
Priority claimed from GBGB9512319.6A external-priority patent/GB9512319D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO972620D0 publication Critical patent/NO972620D0/no
Publication of NO972620L publication Critical patent/NO972620L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO972620A 1994-12-08 1997-06-06 RANTES peptid og fragmenter og blandinger omfattende det for behandling av inflammasjon NO972620L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9424835.8A GB9424835D0 (en) 1994-12-08 1994-12-08 Substances and their uses
GBGB9512319.6A GB9512319D0 (en) 1995-06-16 1995-06-16 Substances and their uses
PCT/GB1995/002861 WO1996017935A2 (en) 1994-12-08 1995-12-07 Rantes peptide and fragments and compositions comprising it for treatment of inflammation

Publications (2)

Publication Number Publication Date
NO972620D0 NO972620D0 (no) 1997-06-06
NO972620L true NO972620L (no) 1997-08-06

Family

ID=26306133

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972620A NO972620L (no) 1994-12-08 1997-06-06 RANTES peptid og fragmenter og blandinger omfattende det for behandling av inflammasjon

Country Status (15)

Country Link
US (2) US6159711A (no)
EP (1) EP0796330A1 (no)
JP (1) JPH10510151A (no)
CN (1) CN1087346C (no)
AU (1) AU688641B2 (no)
BR (1) BR9509890A (no)
CA (1) CA2207036A1 (no)
CZ (1) CZ290850B6 (no)
FI (1) FI972433A0 (no)
HU (1) HU221089B1 (no)
MX (1) MX9703889A (no)
NO (1) NO972620L (no)
NZ (1) NZ296570A (no)
PL (1) PL182786B1 (no)
WO (1) WO1996017935A2 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510151A (ja) * 1994-12-08 1998-10-06 グラクソ、グループ、リミテッド Ｒａｎｔｅｓペプチドおよびフラグメント並びにそれを含んでなる炎症治療用組成物
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
AU4561497A (en) * 1996-09-25 1998-04-17 British Biotech Pharmaceuticals Limited Human rantes mutants incapable of aggregate formation
US6100387A (en) * 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
US6852508B1 (en) 1997-02-28 2005-02-08 Genetics Institute, Llc Chemokine with amino-terminal modifications
IT1291353B1 (it) * 1997-05-12 1999-01-07 San Raffaele Centro Fond Peptidi con attivita' antivirale
US6168784B1 (en) 1997-09-03 2001-01-02 Gryphon Sciences N-terminal modifications of RANTES and methods of use
EP0906954A1 (en) * 1997-09-29 1999-04-07 Applied Research Systems ARS Holding N.V. Amino-terminal truncated c-c chemokines as chemokine antagonist
MXPA00003885A (es) * 1997-10-22 2004-04-23 Inst Genetics Llc Quimiocinas con modificiaciones de la terminacion amino.
DE69832197T2 (de) * 1997-12-23 2006-05-24 Fondazione Centro San Raffaele Del Monte Tabor Rantes-mutanten und therapeutische anwendungen davon
US6121023A (en) * 1998-01-22 2000-09-19 Akzo Nobel N.V. Isothermal transcription based assay for the detection and quantification of the chemokine rantes
EP1000626A1 (en) 1998-09-18 2000-05-17 Applied Research Systems ARS Holding N.V. Chemokine receptor antagonist and cyclosporin in combined therapy
IT1303736B1 (it) * 1998-11-11 2001-02-23 San Raffaele Centro Fond Peptidi derivati da rantes con attivita' anti-hiv.
WO2000056879A1 (en) * 1999-03-22 2000-09-28 Universität Zürich TRANSFORMING GROWTH FACTOR (TFG) β SUPERFAMILY ANTAGONISTS
WO2002020033A1 (en) 2000-09-08 2002-03-14 Gryphon Therapeutics, Inc. Polymer-modified synthetic proteins
US7998681B2 (en) * 2000-10-06 2011-08-16 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Diagnosis and therapy of antibody-mediated inflammatory auto-immune disorders
US8153121B2 (en) * 2000-10-06 2012-04-10 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
EP1506400A2 (en) * 2001-10-30 2005-02-16 President And Fellows Of Harvard College Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
AU2002358144B2 (en) * 2001-12-17 2008-10-02 Laboratoires Serono Sa Chemokine mutants acting as chemokine antagonists
US20040191215A1 (en) * 2003-03-25 2004-09-30 Michael Froix Compositions for induction of a therapeutic response
US7390788B2 (en) * 2005-06-23 2008-06-24 Pert Candace B Peptide pharmaceutical compositions
WO2008015199A1 (en) * 2006-07-31 2008-02-07 Laboratoires Serono S.A. Chemokine antagonists
MX2010001307A (es) 2007-08-02 2010-07-30 Novimmune Sa Anticuerpos anti-proteína regulada con la activación, expresada y secretada por los linfocitos t normales y metodos de uso de los mismos.
US9034313B2 (en) 2010-02-08 2015-05-19 The Trustees Of The University Of Pennsylvania Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
WO2013024022A1 (en) 2011-08-12 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for treatment of pulmonary hypertension
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
US20240409596A1 (en) 2021-10-06 2024-12-12 Virothera Limited Novel immune regulator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510151A (ja) * 1994-12-08 1998-10-06 グラクソ、グループ、リミテッド Ｒａｎｔｅｓペプチドおよびフラグメント並びにそれを含んでなる炎症治療用組成物

Also Published As

Publication number Publication date
MX9703889A (es) 1997-08-30
NO972620D0 (no) 1997-06-06
JPH10510151A (ja) 1998-10-06
FI972433L (fi) 1997-06-06
AU4120896A (en) 1996-06-26
PL320565A1 (en) 1997-10-13
FI972433A7 (fi) 1997-06-06
CZ290850B6 (cs) 2002-10-16
BR9509890A (pt) 1997-12-30
CN1087346C (zh) 2002-07-10
CN1168697A (zh) 1997-12-24
PL182786B1 (pl) 2002-02-28
US6159711A (en) 2000-12-12
AU688641B2 (en) 1998-03-12
US6555105B1 (en) 2003-04-29
EP0796330A1 (en) 1997-09-24
WO1996017935A3 (en) 1996-08-22
HU221089B1 (en) 2002-08-28
CZ171997A3 (en) 1997-11-12
NZ296570A (en) 1998-11-25
HUT77075A (hu) 1998-03-02
CA2207036A1 (en) 1996-06-13
FI972433A0 (fi) 1997-06-06
WO1996017935A2 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
NO972620L (no) RANTES peptid og fragmenter og blandinger omfattende det for behandling av inflammasjon
NO307408B1 (no) Aminosukker og glykosaminglykansammensetning for behandling og reparasjon av bindevev
FI963252L (fi) Kivun hoitoon tarkoitetut uudet opioidipeptidit ja niiden käyttö
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
FI960584L (fi) Terapeuttisia peptidijohdannaisia
HUP9901109A3 (en) Peptide immunogens for vaccination against and treatment of allergy
GB9617021D0 (en) Novel peptides for treatment of inflammation and shock
NO982878D0 (no) Trisykliske amider som er anvendbare for inhibering av G-proteinfunksjon og for behandling av proliferative sykdommer
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO944853D0 (no) Glukagonlignende peptid og insulinotropinderivater
IS2107B (is) Arýlsúlfónamíð og hliðstæður þeirra og notkun þeirra við meðhöndlun taugahrörnunarsjúkdóma
NO972125D0 (no) Hemmoroideblandinger og fremgangsmåte for anvendelse
FI972546L (fi) Ristiinsidotut mikropartikkelit ja niiden käyttö hoitavina apuaineina
DK64592D0 (da) Peptider til terapeutisk behandling
FI954978A7 (fi) Modifioidut proteiini- ja peptidilääkeaineet
IL125446A0 (en) Pharmaceutical composition for the treatment of asthma allergy and inflammation
AU5684594A (en) Novel human amyloid protein precursor homologue and kunitz-type inhibitors
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
MXPA01005600A (es) Peptidos pequenos y metodos para tratamiento de asma e inflamacion.
NO964330L (no) Farmasöytisk sammensetning for terapeutisk behandling av tardiv dyskinesi og anvendelse derav
DE69418931D1 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
IL112681A0 (en) Opioid peptides for the treatment of pain and use thereof
DE69501944D1 (de) Arzneimittel zur Vorbeugung oder Behandlung von chronischem Rheumatismus und Sepsis
EP0502470A3 (en) Compounds for the treatment of inflammation and allergy
FI944224A7 (fi) C-reaktiivisten proteiinifragmenttien osittain modifioidut ja retroinv ertoidut tetrapeptidianalogit

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application